| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.22 | 0.0006 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0006 |